BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32894263)

  • 1. Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study.
    Delvecchio G; Oldani L; Mandolini GM; Pigoni A; Ciappolino V; Schiena G; Lazzaretti M; Caletti E; Barbieri V; Cinnante C; Triulzi F; Brambilla P
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32894263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Willi TS; Lang DJ; Honer WG; Smith GN; Thornton AE; Panenka WJ; Procyshyn RM; Vila-Rodriguez F; Su W; Vertinsky AT; Leonova O; Rauscher A; MacEwan GW; Barr AM
    Schizophr Res; 2016 Oct; 176(2-3):158-163. PubMed ID: 27499362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis-associated psychosis: Neural substrate and clinical impact.
    Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
    Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of cannabis exposure during early versus later adolescence on the expression of psychosis in homeless and precariously housed adults.
    Gicas KM; Cheng A; Panenka WJ; Kim DD; Yau JC; Procyshyn RM; Stubbs JL; Jones AA; Bains S; Thornton AE; Lang DJ; Vertinsky AT; Rauscher A; Honer WG; Barr AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110084. PubMed ID: 32890696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study.
    Koenders L; Cousijn J; Vingerhoets WA; van den Brink W; Wiers RW; Meijer CJ; Machielsen MW; Veltman DJ; Goudriaan AE; de Haan L
    PLoS One; 2016; 11(5):e0152482. PubMed ID: 27224247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis.
    Rapp C; Walter A; Studerus E; Bugra H; Tamagni C; Röthlisberger M; Borgwardt S; Aston J; Riecher-Rössler A
    Psychiatry Res; 2013 Nov; 214(2):102-8. PubMed ID: 24054726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies.
    Rapp C; Bugra H; Riecher-Rössler A; Tamagni C; Borgwardt S
    Curr Pharm Des; 2012; 18(32):5070-80. PubMed ID: 22716152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salience attribution and its relationship to cannabis-induced psychotic symptoms.
    Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD
    Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults.
    Cohen M; Rasser PE; Peck G; Carr VJ; Ward PB; Thompson PM; Johnston P; Baker A; Schall U
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):297-307. PubMed ID: 21557880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fronto-temporal cortical atrophy in 'nyaope' combination heroin and cannabis use disorder.
    Ndlovu NA; Morgan N; Malapile S; Subramaney U; Daniels W; Naidoo J; van den Heuvel MP; Calvey T
    Drug Alcohol Depend; 2021 Apr; 221():108630. PubMed ID: 33667779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White Matter Microstructure and Gray Matter Volume in Cannabis-Induced Psychosis and Schizophrenia With Cannabis Use.
    Shah R; Ghosh A; Avasthi A; Ahuja CK; Khandelwal N; Nehra R
    J Neuropsychiatry Clin Neurosci; 2022; 34(4):406-413. PubMed ID: 35872614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study.
    Altamura AC; Delvecchio G; Paletta S; Di Pace C; Reggiori A; Fiorentini A; Mirabile MD; Paoli RA; Cinnante C; Triulzi F; Mauri MC; Brambilla P
    Psychiatry Res Neuroimaging; 2017 Mar; 261():80-84. PubMed ID: 28161644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
    Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.
    Kaag AM; Schulte MHJ; Jansen JM; van Wingen G; Homberg J; van den Brink W; Wiers RW; Schmaal L; Goudriaan AE; Reneman L
    Drug Alcohol Depend; 2018 Jun; 187():186-194. PubMed ID: 29679913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.
    Penzel N; Antonucci LA; Betz LT; Sanfelici R; Weiske J; Pogarell O; Cumming P; Quednow BB; Howes O; Falkai P; Upthegrove R; Bertolino A; Borgwardt S; Brambilla P; Lencer R; Meisenzahl E; Rosen M; Haidl T; Kambeitz-Ilankovic L; Ruhrmann S; Salokangas RRK; Pantelis C; Wood SJ; Koutsouleris N; Kambeitz J;
    Neuropsychopharmacology; 2021 Jul; 46(8):1484-1493. PubMed ID: 33658653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis.
    Soldevila-Matías P; Schoretsanitis G; Tordesillas-Gutierrez D; Cuesta MJ; de Filippis R; Ayesa-Arriola R; González-Vivas C; Setién-Suero E; Verdolini N; Sanjuán J; Radua J; Crespo-Facorro B
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(2):117-133. PubMed ID: 35840278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.
    Bloomfield MA; Morgan CJ; Egerton A; Kapur S; Curran HV; Howes OD
    Biol Psychiatry; 2014 Mar; 75(6):470-8. PubMed ID: 23820822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-based brain morphometry in schizophrenia vs. cannabis-induced psychosis: A controlled comparison.
    Ghosh A; Kaur S; Shah R; Oomer F; Avasthi A; Ahuja CK; Basu D; Nehra R; Khandelwal N
    J Psychiatr Res; 2022 Nov; 155():286-294. PubMed ID: 36170756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of psychosis on brain anatomy in bipolar disorder: A structural MRI study.
    Altamura AC; Maggioni E; Dhanoa T; Ciappolino V; Paoli RA; Cremaschi L; Prunas C; Orsenigo G; Caletti E; Cinnante CM; Triulzi FM; Dell'Osso B; Yatham L; Brambilla P
    J Affect Disord; 2018 Jun; 233():100-109. PubMed ID: 29223329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.